Written by Klarity Editorial Team
Published: Aug 19, 2026

Last updated: August 19, 2026
Mirtazapine, sold as Remeron and Remeron SolTab, is an antidepressant used for major depressive disorder in adults. It is not an SSRI or SNRI. Many people take it at bedtime because it often causes drowsiness. This guide covers how mirtazapine works, typical doses, appetite and weight changes, rare blood-count and heart-rhythm cautions, and when a video visit is enough to start or continue care.
Considering depression treatment online?
See depression treatment options at Klarity Health →
Browse conditions Klarity treats →
Mirtazapine is an antidepressant that works in the brain. NAMI states it is approved for major depressive disorder. MedlinePlus says it is used to treat depression and works by increasing certain types of activity in the brain to maintain mental balance. DailyMed labels mirtazapine tablets for MDD in adults.
Brand names: Remeron tablets (7.5 mg, 15 mg, 30 mg, 45 mg) and Remeron SolTab orally disintegrating tablets (15 mg, 30 mg, 45 mg), per NAMI. DailyMed lists 7.5 mg unscored, 15 mg scored, 30 mg scored, and 45 mg unscored film-coated tablets.
Related Klarity reads: Effexor (venlafaxine), Cymbalta (duloxetine), Lexapro, Zoloft, Prozac, Celexa, Paxil, Wellbutrin, buspirone.
Mirtazapine is not an SSRI, SNRI, or bupropion. NAMI describes it as an antidepressant that works in the brain for MDD. Clinicians often choose it when sleep disruption, low appetite, or SSRI sexual side effects are part of the picture. That choice is clinical, not a guarantee of those effects for every person.
MedlinePlus notes that the medicine is sometimes prescribed for other uses. Ask your clinician what evidence they are using if the reason is not labeled MDD.
It is not a benzodiazepine. It is not a first-line sleep pill. Sedation is a common effect, which is why labels prefer evening dosing, but that does not make it a controlled hypnotic.
A licensed clinician decides after a history that covers mood, mania risk, sleep, appetite, weight, infection history, heart rhythm and QT risk, glaucoma, kidney or liver disease, cholesterol, pregnancy plans, alcohol, and every medicine and supplement you take. NAMI lists those discussion points, including bipolar screening because antidepressants can switch some people into mania.
DailyMed flags extra caution in older adults and possible dose decreases in moderate to severe renal impairment or hepatic impairment.
This medicine is not right for everyone. People who cannot accept weight gain or next-day drowsiness often need a different plan. People with a history of agranulocytosis on mirtazapine should not restart it without specialist input.
DailyMed: starting dose 15 mg once daily, preferably in the evening prior to sleep; may increase up to a maximum of 45 mg once daily. Reduce the dose gradually when you discontinue.
NAMI: usually once daily at bedtime with or without food; typical range 15 mg to 45 mg; only your clinician can set the dose. SolTab dissolves in the mouth and can be swallowed with or without liquid. Keep ODT tablets in the original blister; open with dry hands; do not put them in a pillbox.
MedlinePlus: once a day at bedtime with or without food. For the disintegrating tablet, open the blister with dry hands, place on the tongue, swallow with saliva; no water needed; use immediately; do not split ODT tablets. If you have PKU, know that ODT tablets contain aspartame that forms phenylalanine.
Missed dose: take it when you remember unless it is almost time for the next dose. Do not double. See MedlinePlus and NAMI.
Strong CYP3A inducers may require a higher mirtazapine dose. Strong CYP3A inhibitors and cimetidine may require a lower dose. Monitor INR if you take warfarin. See DailyMed.
NAMI: sleep, energy, or appetite may improve in 1 to 2 weeks. Depressed mood and lack of interest may need up to 6 to 8 weeks. MedlinePlus: it may take several weeks or longer to feel the full benefit. Keep taking it even if you feel well, unless your clinician changes the plan.
Do not stop suddenly. NAMI lists withdrawal symptoms after an abrupt stop: irritability, nausea, dizziness, vomiting, nightmares, headache, and/or paresthesias. DailyMed also says to reduce the dose gradually.
DailyMed most common adverse reactions (≥5% and twice placebo): somnolence, increased appetite, weight gain, and dizziness. NAMI adds increased cholesterol and triglyceride levels. MedlinePlus lists drowsiness, dizziness, and increased weight and appetite as effects that can persist.
Serious issues to treat as urgent:
Alcohol can worsen sedation. Do not drive until you know how you react. See MedlinePlus and NAMI.
Do not combine with MAOIs (isocarboxazid, phenelzine, tranylcypromine, selegiline, rasagiline) or use within 14 days. Linezolid and IV methylene blue are also stops. See DailyMed, MedlinePlus, and NAMI.
Serotonin risk rises with other antidepressants, triptans, tramadol, St. John’s wort, and tryptophan. Cimetidine can change levels. Tell your clinician about all OTC products. See MedlinePlus and DailyMed.
Warfarin: monitor INR. Strong CYP3A inducers or inhibitors: dose may need to change. See DailyMed.
Mirtazapine is not a controlled substance on the labels retrieved for this article. Many adults can start or continue it by video if the clinician can take a full history, screen for bipolar disorder, review meds, and arrange labs when infection symptoms or metabolic concerns appear.
In-person care is a better fit after unexplained fever or sore throat, new chest pain or fainting, eye-pain emergencies, pregnancy questions that need obstetric input, or if you cannot swallow or keep ODT tablets dry and intact.
Medicare patients can permanently receive behavioral telehealth in the home, with no geographic originating-site restriction, including audio-only when video is not possible. The extra in-person visit rule is waived through December 31, 2027. See HHS telehealth policy.
Klarity Health connects you with 2,000+ licensed providers for online evaluation and medication management when clinically appropriate. A visit can cover whether mirtazapine, an SSRI, an SNRI, or another option fits your sleep, appetite, and side-effect priorities.
See online depression treatment options →
Insurance coverage may vary by plan. Prior authorization and formulary tier differ. Verify benefits before you book. This article is educational and is not a diagnosis or a promise that any medicine will be prescribed.
If you are in crisis, call or text 988. If this is a medical emergency, call 911.
Remeron is a brand name for mirtazapine. Remeron SolTab is the orally disintegrating tablet. Generics use the same active ingredient. See NAMI and MedlinePlus.
Somnolence is common. DailyMed prefers evening dosing before sleep. That does not make it a dedicated sleep medicine.
Increased appetite and weight gain are among the most common labeled effects. Discuss this before you start if weight is a concern. See DailyMed and NAMI.
Often yes, when a licensed clinician can complete a full evaluation and follow-up. Coverage may vary by plan. Verify benefits. See HHS policy for Medicare behavioral telehealth rules.
Many adults start at 15 mg at bedtime. The labeled maximum is 45 mg once daily. Your clinician may use 7.5 mg in some cases. See DailyMed and NAMI.
Disclaimer: Coverage and prescribing decisions vary by clinician, state law, and plan. Verify your benefits and follow your clinician’s instructions. This page does not replace medical advice.
Find the right provider for your needs — select your state to find expert care near you.